nilvadipine has been researched along with Cardiac Failure in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute hemodynamic effects of nilvadipine, a newly synthesized calcium channel blocker, were studied in 12 patients with congestive heart failure." | 7.68 | Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. ( Aoyagi, T; Iizuka, M; Ikenouchi, H; Matsui, H; Mochizuki, T; Momomura, S; Sato, H; Serizawa, T; Sugimoto, T, 1990) |
| " We conclude that the long-term administration of nilvadipine (16 mg daily) is neither effective nor harmful in the treatment of patients with chronic heart failure." | 6.67 | Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. ( Hayashi, T; Hoki, N; Hori, M; Kamada, T; Karita, M; Kodama, K; Naka, M; Nanto, S; Sato, H; Yamada, Y, 1994) |
| "The acute hemodynamic effects of nilvadipine, a newly synthesized calcium channel blocker, were studied in 12 patients with congestive heart failure." | 3.68 | Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. ( Aoyagi, T; Iizuka, M; Ikenouchi, H; Matsui, H; Mochizuki, T; Momomura, S; Sato, H; Serizawa, T; Sugimoto, T, 1990) |
| " We conclude that the long-term administration of nilvadipine (16 mg daily) is neither effective nor harmful in the treatment of patients with chronic heart failure." | 2.67 | Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. ( Hayashi, T; Hoki, N; Hori, M; Kamada, T; Karita, M; Kodama, K; Naka, M; Nanto, S; Sato, H; Yamada, Y, 1994) |
| "Nilvadipine is a new calcium antagonist of the dihydropyridine type." | 2.38 | Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist. ( Honerjäger, P; Seibel, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, M | 1 |
| Sato, H | 2 |
| Karita, M | 1 |
| Kodama, K | 1 |
| Hoki, N | 1 |
| Hayashi, T | 1 |
| Naka, M | 1 |
| Nanto, S | 1 |
| Yamada, Y | 1 |
| Kamada, T | 1 |
| Honerjäger, P | 1 |
| Seibel, K | 1 |
| Ikenouchi, H | 1 |
| Aoyagi, T | 1 |
| Matsui, H | 1 |
| Mochizuki, T | 1 |
| Momomura, S | 1 |
| Serizawa, T | 1 |
| Iizuka, M | 1 |
| Sugimoto, T | 1 |
1 review available for nilvadipine and Cardiac Failure
| Article | Year |
|---|---|
Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Heart; | 1992 |
1 trial available for nilvadipine and Cardiac Failure
| Article | Year |
|---|---|
Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study.
Topics: Calcium Channel Blockers; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Hemodynami | 1994 |
1 other study available for nilvadipine and Cardiac Failure
| Article | Year |
|---|---|
Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Calcium Channel Blockers; Female; Heart Failure; Hemodynami | 1990 |